Representative before the EPO

Company dna inserm transfert ip department 7 rue watt
no operation time available
Headquarter in Paris
Technology Transfer Office

We have observed 105 EP applications Matthieu Collin has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after February 10, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12729116

NKp46-MEDIATED NK CELL TUNING

IPC classification:
A61K 38/17, A61K 39/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Innate Pharma SA
Applicant:
Université de la Méditerranée - Aix-Marseille II
Agent:
Matthieu Collin, Inserm Transfert
Agent:
Lukas Völlmy, Innate Pharma SA
Status:
GRANT OF PATENT INTENDED
EP14721259

METHODS AND KITS FOR TESTING THE GENOTOXICITY OF AN AGENT

IPC classification:
G01N 33/50
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Rouen
Applicant:
Centre Hospitalier Universitaire de Rouen
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14718603

METHODS FOR STIMULATING ANTIGEN-SPECIFIC T CELL RESPONSES

IPC classification:
G01N 33/50, G01N 33/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14725123

FGF23 AS A BIOMARKER FOR PREDICTING THE RISK OF MORTALITY DUE TO END STAGE LIVER DISEASE

IPC classification:
G01N 33/74
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14728216

BIOMARKER OF REHOSPITALIZATION AFTER HEART FAILURE

IPC classification:
G01N 33/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Centre Hospitalier Universitaire de Toulouse
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14726637

USE OF URINARY HIV NUCLEIC ACIDS TO DIAGNOSE AND MONITOR HIV-ASSOCIATED NEPHROPATHY (HIVAN)

IPC classification:
C12Q 1/70
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14732529

RAC1 INHIBITORS FOR INDUCING BRONCHODILATION

IPC classification:
A61K 31/496, A61K 45/00, A61P 11/06, A61P 11/08
Applicant:
Université de Nantes
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Centre Hospitalier Universitaire Nantes
Agent:
Cabinet Lavoix
Agent:
Matthieu Collin, Inserm Transfert
Status:
GRANT OF PATENT INTENDED
EP14729335

ANTI-HER2 SINGLE DOMAIN ANTIBODIES, POLYPEPTIDES COMPRISING THEREOF AND THEIR USE FOR TREATING CANCER

IPC classification:
A61K 39/00, C07K 16/32
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14730859

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ERYTHROPOIETIC PROTOPORPHYRIA

IPC classification:
A61K 31/7125, A61P 7/00, A61P 17/00, C12N 15/113
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14731639

PHARMACEUTICAL COMPOSITIONS FOR PREVENTING GLUCOCORTICOID-INDUCED CORNEAL OR SKIN THINNING

IPC classification:
A61K 9/00, A61K 9/06, A61K 9/08, A61K 31/573, A61K 31/585, A61P 17/00, A61P 27/02, A61P 29/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14735542

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

IPC classification:
A61K 38/20, A61P 11/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Droit et de la Santé de Lille 2
Applicant:
Université Lille 1 Sciences et Technologies
Agent:
Matthieu Collin, Inserm Transfert
Status:
GRANT OF PATENT INTENDED
EP14735525

INTERLEUKIN 15 (IL-15) ANTAGONISTS AND USES THEREOF FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES

IPC classification:
A61K 38/20, C07K 14/54, C12N 15/00, C12N 15/62
Applicant:
Université d'Angers
Applicant:
Université de Nantes
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14733199

METHODS FOR EXPRESSING A POLYNUCLEOTIDE OF INTEREST IN THE RETINA OF A SUBJECT

IPC classification:
C07K 14/47, C12N 7/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Agent:
Matthieu Collin, Inserm Transfert
Status:
GRANT OF PATENT INTENDED
EP14735579

NOVEL ALTERNATIVE SPLICE TRANSCRIPTS FOR MHC CLASS I RELATED CHAIN ALPHA (MICA) AND USES THEREOF

IPC classification:
A61K 38/00, C07K 14/47, C12N 5/00
Applicant:
Université de Nantes
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14737236

METHODS FOR PERFORMING ANTISENSE OLIGONUCLEOTIDE-MEDIATED EXON SKIPPING IN THE RETINA OF A SUBJECT IN NEED THEREOF

IPC classification:
A61K 31/7088, C12N 15/113
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Cabinet Lavoix
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14744575

METHODS AND KITS FOR IDENTIFYING EFFECTOR TREG CELLS

IPC classification:
G01N 33/569
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
GRANT OF PATENT INTENDED
EP14741881

ANTI-CLAUDIN 1 ANTIBODIES FOR USE IN THE TREATMENT OF COLORECTAL CANCER

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14746985

ANTI-CLAUDIN 1 ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/18
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14755794

IMMUNOADJUVANT COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 39/39
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université Paul Sabatier Toulouse III
Agent:
Matthieu Collin, Inserm Transfert
Status:
GRANT OF PATENT INTENDED
EP14766928

METHODS FOR DETERMINING HUMAN SPERM QUALITY

IPC classification:
C12Q 1/48, G01N 33/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Droit et de la Santé de Lille 2
Applicant:
Centre Hospitalier Régional et Universitaire de Lille
Agent:
Matthieu Collin, Inserm Transfert
Agent:
Valérie Schwalek, SCB S.A.S.
Status:
GRANT OF PATENT INTENDED
EP14766458

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS

IPC classification:
A61K 31/712, A61P 11/00, A61P 43/00, C12N 15/113
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14766503

LENTIVIRAL VECTORS HAVING A MUTATED INTEGRASE PROTEIN AND USES THEREOF

IPC classification:
C07K 14/005, C12N 15/86
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Matthieu Collin, Inserm Transfert
Status:
GRANT OF PATENT INTENDED
EP14766481

METHOD AND PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF EPILEPSY

IPC classification:
A61K 31/513, A61P 25/08
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Agent:
Matthieu Collin, Inserm Transfert
Status:
GRANT OF PATENT INTENDED
EP14786873

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF POLYOMAVIRUS INFECTIONS

IPC classification:
A61K 31/7068, A61P 13/12, A61P 31/20, A61P 35/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Les Hospices Civils de Lyon
Applicant:
Université Claude Bernard Lyon I (UCBL)
Applicant:
Ecole Normale Supérieure de Lyon
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP14793193

NEW ALZHEIMER'S DISEASE ANIMAL MODEL

IPC classification:
A01K 67/027, C07K 14/47, C12N 15/85, C12N 15/86, G01N 33/50
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP13836207

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PANCREATIC CANCERS

IPC classification:
A61K 38/17, A61P 35/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP14799415

A RHO GTPASE ACTIVATOR FOR USE AS ANTIMICROBIAL AGENT

IPC classification:
A61K 38/16, A61K 39/39, A61P 31/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Nice (Université Nice Sophia Antipolis)
Applicant:
Centre Hospitalier Universitaire de Nice
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP14808905

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BETA-THALASSEMIAS

IPC classification:
A61K 31/396, A61P 7/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP14806623

MAFB MUTANTS AND USES THEREOF

IPC classification:
C07K 14/47, C07K 14/82
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Europäisches Laboratorium für Molekularbiologie (European Molecular Biology Laboratory (EMBL), Heidelberg)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP14809410

METHODS FOR ADHERING TISSUE SURFACES AND MATERIALS AND BIOMEDICAL USES THEREOF

IPC classification:
A61K 9/70, A61K 31/695, A61K 33/00, A61K 38/48, A61K 45/06, A61K 47/02, A61L 24/00, A61L 26/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
Paris 13 University (Universite Paris 13 Nord)
Applicant:
Ecole Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP14833136

METHODS FOR THE PREVENTION AND TREATMENT OF DIABETIC CARDIOMYOPATHY USING MIR-424/322

IPC classification:
A61K 48/00, C12N 15/864
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP14809644

METHOD AND PHARMACEUTICAL COMPOSITION FOR INHIBITING NEURONAL REMODELING

IPC classification:
C07K 16/18, C07K 16/28, C07K 16/30, C12N 15/113
Applicant:
Assistance Publique Hôpitaux de Marseille
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14824852

COMBINATION OF AN ARSENIC COMPOUND AND AT LEAST ONE RETINOID FOR TREATING ACUTE MYELOID LEUKEMIA

IPC classification:
A61K 31/203, A61K 31/285, A61K 33/36, A61P 35/02
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP15700100

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR REDUCING METASTATIC DISSEMINATION

IPC classification:
A61K 31/164, A61P 35/04, G01N 33/50
Applicant:
Université de Bourgogne Dijon
Applicant:
Université de Rennes 1
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Centre Hospitalier Universitaire de Toulouse
Applicant:
University of the French West Indies and Guiana (Université des Antilles et da la Guyane)
Applicant:
Ecoles des Hautes en Sante Publique (EHESP)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15703742

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMAS

IPC classification:
A61K 31/47, A61K 31/4709, A61K 38/17, A61K 38/22, A61K 39/00, A61K 45/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15703741

METHODS FOR THE PREVENTION AND THE TREATMENT OF EXTRACAPILLARY GLOMERULONEPHRITIS

IPC classification:
A61K 31/713, A61P 13/12, C12N 15/113
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15702743

SOLUBLE MONOMERIC ANTI-MULLERIAN HORMONE RECEPTOR TYPE II FUSION PROTEINS AND USES THEREOF

IPC classification:
C07K 14/71, C12N 15/62
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15705274

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

IPC classification:
A61K 31/7032, A61K 39/00, C07K 16/28
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université de Droit et de la Santé de Lille 2
Applicant:
Université Lille 1 Sciences et Technologies
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15704806

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES MEDIATED BY THE NRP-1/OBR COMPLEX SIGNALING PATHWAY

IPC classification:
G01N 33/50, G01N 33/574
Applicant:
Université de Bourgogne Dijon
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15705594

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER

IPC classification:
C07K 14/47, C12N 15/62
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15708510

CARBAPENEMASE AND ANTIBACTERIAL TREATMENT

IPC classification:
C12N 9/86
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15709213

DIAGNOSIS METHOD FOR LUPUS

IPC classification:
G01N 33/564
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15708545

METHODS AND KITS FOR CLASSIFYING DIFFUSE LARGE B-CELL LYMPHOMAS (DLBCLs) INTO GCB-DLBCLs OR INTO ABC-DLBCLs

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Rouen
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15710188

METHODS FOR PREDICTING ACUTE REJECTION IN HEART RECIPIENTS

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15710530

A METHOD FOR INDUCING HUMAN CHOLANGIOCYTE DIFFERENTIATION

IPC classification:
C12N 5/071
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15711162

TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS EPAC1 INHIBITORS FOR THE TREATMENT OF MYOCARDIAL INFARCTION INJURY

IPC classification:
A61K 31/47, A61K 45/06, A61P 9/10
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paul Sabatier Toulouse III
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15712159

NEW BIOMARKER FOR OUTCOME IN AML PATIENTS

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15713503

AN ISOLATED DONOR MHC-DERIVED PEPTIDE AND USES THEREOF

IPC classification:
C07K 14/435
Applicant:
Université de Nantes
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15713778

NEW METHOD FOR PRODUCING OUTER MEMBRANE VESICLES

IPC classification:
A61K 39/00, C12N 1/06
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Institut National de la Recherche Agronomique (INRA)
Applicant:
Centre Hospitalier Universitaire de Toulouse
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15716069

ANTIBODIES FOR THE PREVENTION OR THE TREATMENT OF BLEEDING EPISODES

IPC classification:
A61K 39/395, A61P 7/04, C07K 16/36
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Université de Droit et de la Santé de Lille 2
Agent:
Nicolas Marro, Cabinet Beau de Loménie (CBDL)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15715758

POLYPEPTIDES AND USES THEREOF FOR REDUCING CD95-MEDIATED CELL MOTILITY

IPC classification:
C07K 14/435
Applicant:
University of Nottingham
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Bordeaux
Applicant:
University of the French West Indies and Guiana (Université des Antilles et da la Guyane)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15718902

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VASO-OCCLUSIVE CRISIS

IPC classification:
A61K 38/17, A61K 38/43, A61K 38/46, A61P 7/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15724533

NEW BIOMARKER FOR AML

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15723913

MIF INHIBITORS FOR THE ACUTE OR CHRONIC TREATMENT OF PULMONARY HYPERTENSION

IPC classification:
A61K 31/423, A61P 11/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Matthieu Collin, Inserm Transfert
Agent:
Icosa
Status:
EXAMINATION REQUESTED
EP15725258

NEW METHOD FOR TREATING MELANOMA

IPC classification:
A61K 38/17, A61K 39/395, A61P 35/00, C07K 16/24, C07K 16/28, C07K 16/30
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Centre Hospitalier Universitaire de Toulouse
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15723721

ANTI- EGFR CONFORMATIONAL SINGLE DOMAIN ANTIBODIES AND USES THEREOF

IPC classification:
C07K 16/28
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15729772

ANTI-NEUROTENSIN ANTIBODIES AND USES THEREOF

IPC classification:
A61K 33/24, A61K 39/00, A61K 39/395, C07K 16/26
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15726593

ANTI-NEUROTENSIN LONG FRAGMENT ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/00, A61P 35/00, C07K 16/18, C07K 16/30
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15728519

PHARMACEUTICAL COMPOSITIONS COMPRISING AN AT2R AGONIST FOR TREATING PAIN

IPC classification:
A61K 31/365, A61P 29/00
Applicant:
Université d'Angers
Applicant:
Université de Nantes
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
University of Nice (Université Nice Sophia Antipolis)
Applicant:
Université de Droit et de la Santé de Lille 2
Applicant:
Université Lille 1 Sciences et Technologies
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15726633

PHARMACEUTICAL COMPOSITIONS FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASES

IPC classification:
A61K 38/16, C07K 14/005
Applicant:
ICM - Institut du Cerveau et da la Moelle Epinière
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
Université Paul Sabatier Toulouse III
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15731531

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES

IPC classification:
A61K 31/165, A61P 35/02
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15728015

METHODS AND COMPOSITIONS FOR DIAGNOSING, MONITORING AND TREATING CANCER

IPC classification:
G01N 33/574
Applicant:
Université de Bourgogne Dijon
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Cabinet Plasseraud
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15731951

METHODS EMPLOYING CIRCULATING DNA AND MIRNA AS BIOMARKERS FOR FEMALE INFERTILITY

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre Hospitalier Universitaire de Montpellier
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15731937

FREE NUCLEIC ACIDS AND MIRNA AS NON-INVASIVE METHOD FOR DETERMINING EMBRYO QUALITY

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre Hospitalier Universitaire de Montpellier
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15734351

ANTI- MGLUR2 CONFORMATIONAL SINGLE DOMAIN ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/395, A61P 25/00, C07K 16/28
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15735940

A NEW BIOMARKER OF CHRONIC ALLOGRAFT NEPHROPATHY AND OF RENAL TRANSPLANT REJECTION

IPC classification:
A61K 39/00, G01N 33/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15734409

METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIC PAIN

IPC classification:
A61K 31/713, C12N 15/113
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15738898

METHODS FOR THE INTERCELLULAR TRANSFER OF ISOLATED MITOCHONDRIA IN RECIPIENT CELLS

IPC classification:
A61K 35/12, C12N 5/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre Hospitalier Universitaire de Montpellier
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15738908

AN ISOLATED INTERLEUKIN-34 POLYPEPTIDE FOR USE IN PREVENTING TRANSPLANT REJECTION AND TREATING AUTOIMMUNE DISEASES

IPC classification:
A61K 38/20, A61P 37/06
Applicant:
Université de Nantes
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15731560

PHARMACEUTICAL COMPOSITIONS COMPRISING AGONISTS OF OREXIN-1 RECEPTOR OX1R FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES

IPC classification:
A61K 38/17, A61K 38/22, A61P 1/04, A61K 47/56
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15760171

METHODS OF DIAGNOSING AND TREATING CANCER

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paul Sabatier Toulouse III
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP15766500

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS

IPC classification:
A61K 31/435, A61K 31/496, A61K 45/00, A61P 11/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP15780771

IMMUNOLOGICAL TREATMENT OF CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY

IPC classification:
A61K 39/00, A61K 39/395, C07K 16/28
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP15816218

METHODS FOR SCREENING A SUBJECT FOR A CANCER

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP15790561

METHOD FOR IDENTIFYING IN A SUBJECT TUMOUR CELLS BEARING A T315I MUTATION

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
University of Poitiers (Université de Poitiers)
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP15794141

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/435, A61K 31/47, A61K 31/5513, A61K 45/06, A61P 35/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP15797960

METHODS OF DIAGNOSING CANCER AND OF PREDICTING RESPONSE OF CANCER TO DENDROGENIN A TREATMENT

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paul Sabatier Toulouse III
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP15800811

POLYPEPTIDES FOR THE TREATMENT OF ANGIOGENESIS OR LYMPHANGIOGENESIS-RELATED DISEASES

IPC classification:
A61K 38/00, C07K 14/705, C07K 16/28, C12N 15/62
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP15798424

TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY ANTAGONISM OF THE IL-20R.

IPC classification:
A61K 39/00, C07K 16/24, C07K 16/28
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université de Droit et de la Santé de Lille 2
Applicant:
Université Lille 1 Sciences et Technologies
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP15798429

USE OF OX1R ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES

IPC classification:
A61K 31/00, A61K 31/4545, A61P 1/08, A61P 1/12
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP15808183

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTIONS

IPC classification:
A61K 31/7088, C12N 15/113
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
Institut Gustave Roussy
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Institut Pasteur - Transfert de technologie et entrepreneuriat
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP15805233

HUMAN MONOCLONAL ANTIBODIES AGAINST AXL

IPC classification:
A61K 39/00, A61K 39/395, C07K 16/28
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Cabinet Plasseraud
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP15817381

ALPHA-CELL RE-GENERATION COMBINED WITH CONVERSION TO BETA CELLS

IPC classification:
A61K 31/197, A61K 35/39, A61K 39/00, A61K 45/06, A61P 3/10, C12N 5/071
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP15817861

METABOLICALLY STABLE APELIN ANALOGS IN THE TREATMENT OF DISEASE MEDIATED BY THE APELIN RECEPTOR

IPC classification:
C07K 7/08, C07K 14/47
Applicant:
Université de Strasbourg
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP15817376

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

IPC classification:
A61K 38/16
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université de Droit et de la Santé de Lille 2
Applicant:
Université Lille 1 Sciences et Technologies
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP15817338

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL SUPERINFECTIONS POST-INFLUENZA

IPC classification:
A61K 38/16, A61P 31/04
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université de Droit et de la Santé de Lille 2
Applicant:
Université Lille 1 Sciences et Technologies
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16700152

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ISCHEMIC CONDITIONS

IPC classification:
A61K 38/16, A61K 38/17, A61K 38/18, A61K 38/49, A61K 45/06, A61P 9/10
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16700156

MUTATED FACTOR X POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF HAEMOPHILIA

IPC classification:
A61K 38/36, A61K 38/48, C07K 14/745, C12N 9/64
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16700493

HUMAN MONOCLONAL ANTIBODIES AGAINST OREXIN RECEPTOR TYPE 1

IPC classification:
A61K 39/00, C07K 16/28, C07K 16/30
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Institut régional du Cancer Montpellier / Val d’Aurelle
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16700495

HUMAN MONOCLONAL ANTIBODIES AGAINST OREXIN RECEPTOR TYPE 1

IPC classification:
A61K 39/00, C07K 16/28, C07K 16/30
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Institut régional du Cancer Montpellier / Val d’Aurelle
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16700279

METHODS FOR THE DIAGNOSIS OF PANCREATIC CANCER

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Centre Hospitalier Universitaire de Toulouse
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16702068

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF EBOLA VIRUS DISEASE

IPC classification:
A61K 31/4965, A61P 31/14
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Bordeaux
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16702550

ANTI-RHO GTPASE CONFORMATIONAL SINGLE DOMAIN ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/12, C07K 16/18
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paul Sabatier Toulouse III
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16704599

METHODS FOR PREDICTING THE RESPONSIVENESS OF A PATIENT AFFECTED WITH MALIGNANT HEMATOLOGICAL DISEASE TO CHEMOTHERAPY TREATMENT AND METHODS OF TREATMENT OF SUCH DISEASE

IPC classification:
A61K 38/18, C12Q 1/68, G01N 33/574
Applicant:
Université d'Angers
Applicant:
Université de Nantes
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Centre Hospitalier Universitaire d'Angers
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16704213

POLYPEPTIDES FOR ENGINEERING INTEGRASE CHIMERIC PROTEINS AND THEIR USE IN GENE THERAPY

IPC classification:
A61K 48/00, C07K 19/00, C12N 9/22, C12N 15/62, C12N 15/867
Applicant:
CEA (Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16705174

METHODS FOR ON DEMAND PRE-EXPOSURE PROPHYLACTIC TREATMENT OF HIV INFECTION

IPC classification:
A61K 31/513, A61K 31/675, A61P 31/18
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16705179

OREXIN-B POLYPEPTIDES AND USES THEREOF

IPC classification:
A61K 38/17
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16707151

FGFR3 ANTAGONISTS

IPC classification:
A61K 31/4245, C07D 413/04
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16707767

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HIV INFECTION

IPC classification:
A61K 31/7088, A61P 31/18, C12N 15/115
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université de Bordeaux
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16707709

NEW METHOD FOR TREATING AND PROGNOSING CANCER

IPC classification:
A61K 38/00, G01N 33/574
Applicant:
Université d'Angers
Applicant:
Université de Nantes
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16709394

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FILOVIRUS INFECTIONS

IPC classification:
A61K 31/7105, C12N 15/113, C12N 15/115
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Bordeaux
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16709287

ANTIBODIES SPECIFIC TO GLYCOPROTEIN (GP) OF EBOLA VIRUS AND USES FOR THE TREATMENT AND DIAGNOSIS OF EBOLA VIRUS INFECTION

IPC classification:
C07K 16/10
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université Claude Bernard Lyon I (UCBL)
Applicant:
Ecole Normale Supérieure de Lyon
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16712794

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF NEUROLOGICAL PHENOTYPE ASSOCIATED WITH FRIEDREICH ATAXIA

IPC classification:
A61K 48/00, C07K 14/47, C12N 15/86
Applicant:
Université de Strasbourg
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16712805

METHOD AND PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF DIABETES

IPC classification:
A61K 38/17, A61P 3/10
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Centre Hospitalier Universitaire de Toulouse
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP16723255

NEW BIOMARKER FOR OUTCOME IN AML

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made

Please Sign in to use this feature